16 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Dropseye disorder, myopia, refractive errorNot yet recruitingNot applicable2026-09-29NCT07846787
Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Controleye disorder, myopia, refractive errorActive, not recruitingNot applicable2026-08-18NCT06667037
Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD PatientsNeovascular Age-Related Macular Degeneration (nAMD) Wet AMDNot yet recruitingEarly phase 12026-07-27NCT07728981
Impact of Various Myopia Management Strategies on Asthenopia Among Pediatric and Adolescent Populationsasthenopia, eye disorder, myopia, refractive errorNot yet recruitingNot stated2026-07-09NCT07691671
Efficacy of Different Interventions for Progressive Myopia After Orthokeratology Lens WearMyopia, Progressive, degenerative myopia, eye disorder, myopia, refractive errorNot yet recruitingNot stated2026-04-01NCT07494799
PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia PreventionPre-myopiaNot yet recruitingPhase 1 / Phase 22026-03-04NCT07449247
Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencieseye disorder, myopia, refractive errorNot yet recruitingNot applicable2025-09-22NCT07186088
Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapyeye disorder, myopia, refractive errorRecruitingNot applicable2025-09-15NCT07160036
Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMDnAMDRecruitingPhase 1 / Phase 22025-09-04NCT06672536
Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote Chinaeye disorder, myopia, refractive errorEnrolling by invitationNot stated2025-08-13NCT07119723
Aqueous Humor Proteome in Retinal Vein Occlusion With Macular EdemaEmbolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorderActive, not recruitingNot stated2025-08-07NCT07106268
CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)Neovascular Age-related Macular Degeneration(nAMD)RecruitingEarly phase 12025-03-17NCT06031727
Neoadjuvant Radiotherapy for Malignant Lacrimal Sac TumorsMalignant Tumor of Lacrimal Drainage StructureRecruitingNot applicable2025-02-25NCT04016675
Gene Therapy(FT-003) for Wet AMDNeovascular Age-related Macular DegenerationRecruitingPhase 1 / Phase 22024-07-09NCT06492863
Gene Therapy for Diabetic Macular Edemadiabetic macular edemaRecruitingPhase 12023-06-23NCT05916391
Gene Therapy for Wet AMDNeovascular Age-related Macular DegenerationNot yet recruitingPhase 12023-04-26NCT05611424